College of Basic Medical Sciences, Navy Military Medical University, Shanghai, China.
Department of Medical Oncology, 10th People's Hospital, Tongji University, Shanghai, China.
Curr Probl Cancer. 2019 Feb;43(1):66-74. doi: 10.1016/j.currproblcancer.2018.07.005. Epub 2018 Jul 21.
Lung cancer is the leading cause of cancer death worldwide, and the predominant risk factor for its development is smoking. Thymidylate synthase (TYMS) is a key enzyme in DNA synthesis that catalyzes the conversion of deoxyuridine monophosphate to dTMP. Rs931794, a single nucleotide polymorphism located in the TYMS gene, was suggested to be associated with cancer risk.
To analyze the interaction between rs3819102 and environmental factors on the risk of lung cancer in a Chinese population, single nucleotide polymorphismscan was used to genotype this polymorphism in 974 lung cancer cases and 1005 control subjects.
The frequencies of TT, CT, and CC genotypes of TYMS rs3819102 were 61.8%, 32.9%, and 5.3% in controls, and 53.8%, 38.4%, and 7.8% in cases, respectively. Compared with the TT genotype, the CT (odds ratio [OR], 1.380; 95% confidence interval [CI], 1.131-1.683), and CC (OR, 1.786; 95% CI, 1.213-2.644) genotypes were associated with an increased risk of lung cancer after adjustment for age, gender, smoking status, and family history. The C allele of rs3819102 is the risk allele for lung carcinogenesis in a dominant model (OR, 1.435; 95% CI, 1.188-1.735). In a stratified analysis, the risk effects of both the CT and CC genotypes of rs3819102 were more evident in subgroups of smokers and people without a family history of cancer.
The rs3819102 polymorphism in TYMS might increase susceptibility to environmental factors and contribute to the risk of lung cancer. The C allele is a risk allele in lung carcinogenesis.
肺癌是全球癌症死亡的主要原因,其发展的主要危险因素是吸烟。胸苷酸合成酶(TYMS)是 DNA 合成中的关键酶,可催化脱氧尿苷单磷酸转化为 dTMP。位于 TYMS 基因中的单核苷酸多态性 rs931794 被认为与癌症风险相关。
为了分析 rs3819102 与环境因素在中国人群中对肺癌风险的相互作用,使用单核苷酸多态性检测技术对 974 例肺癌病例和 1005 例对照中的该多态性进行基因分型。
TYMS rs3819102 的 TT、CT 和 CC 基因型的频率在对照组中分别为 61.8%、32.9%和 5.3%,在病例组中分别为 53.8%、38.4%和 7.8%。与 TT 基因型相比,CT(比值比[OR],1.380;95%置信区间[CI],1.131-1.683)和 CC(OR,1.786;95%CI,1.213-2.644)基因型在调整年龄、性别、吸烟状况和家族史后与肺癌风险增加相关。rs3819102 的 C 等位基因是肺癌发生的风险等位基因,呈显性模式(OR,1.435;95%CI,1.188-1.735)。在分层分析中,rs3819102 的 CT 和 CC 基因型的风险效应在吸烟者和无癌症家族史的亚组中更为明显。
TYMS 中的 rs3819102 多态性可能增加对环境因素的易感性,并导致肺癌的风险增加。C 等位基因是肺癌发生的风险等位基因。